Skip to Main Content

Author Details

Madeleine Moussa
Schulich School of Medicine and Dentistry, University of Western Ontario
1989
81
25
PMIDPaper TitleJournal TitlePublished Year
37439809Neoadjuvant Cabazitaxel plus Abiraterone/Leuprolide Acetate in Patients with High-Risk Prostate Cancer: ACDC-RP Phase II Trial.Clin Cancer Res2023
37126232Multimodal Biomarkers That Predict the Presence of Gleason Pattern 4: Potential Impact for Active Surveillance.J Urol2023
37081426The use of Lutetium-177 PSMA radioligand therapy with high dose rate brachytherapy for locally recurrent prostate cancer after previous definitive radiation therapy: a randomized, single-institution, phase I/II study (ROADSTER).BMC Cancer2023
35337747Targeting prostate lesions on multiparametric MRI with HDR brachytherapy: Optimal planning margins determined using whole-mount digital histology.Brachytherapy2022
36095953Prostate cancer classification using radiomics and machine learning on mp-MRI validated using co-registered histology.Eur J Radiol2022
32779056Stochastic Sequential Modeling: Toward Improved Prostate Cancer Diagnosis Through Temporal-Ultrasound.Ann Biomed Eng2021
33648893A multiobserver study investigating the effectiveness of prostatic multiparametric magnetic resonance imaging to dose escalate corresponding histologic lesions using high-dose-rate brachytherapy.Brachytherapy2021
34589619Prostate specific membrane antigen positron emission tomography for lesion-directed high-dose-rate brachytherapy dose escalation.Phys Imaging Radiat Oncol2021
34652551Short-duration dynamic [<sup>18</sup>F]DCFPyL PET and CT perfusion imaging to localize dominant intraprostatic lesions in prostate cancer: validation against digital histopathology and comparison to [<sup>18</sup>F]DCFPyL PET/MR at 120 minutes.EJNMMI Res2021
33994184Clinical Significance of Isolated V1 Arteritis in Renal Transplantation.Transplant Proc2021
33394284Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [<sup>18</sup>F]DCFPyL-PET: comparison to [<sup>18</sup>F]fluorocholine-PET.EJNMMI Res2021
30964839Renal Lymphangiectasia in the Transplanted Kidney: Case Series and Literature Review.Transplantation2020
31708295Randomized Study of Systematic Biopsy Versus Magnetic Resonance Imaging and Targeted and Systematic Biopsy in Men on Active Surveillance (ASIST): 2-year Postbiopsy Follow-up.Eur Urol2020
32715024Automatic cancer detection on digital histopathology images of mid-gland radical prostatectomy specimens.J Med Imaging (Bellingham)2020
32827589Histologic validation of auto-contoured dominant intraprostatic lesions on [<sup>18</sup>F] DCFPyL PSMA-PET imaging.Radiother Oncol2020
32901381Correction to: Stochastic Sequential Modeling: Toward Improved Prostate Cancer Diagnosis Through Temporal-Ultrasound.Ann Biomed Eng2020
32555410Histologic tissue components provide major cues for machine learning-based prostate cancer detection and grading on prostatectomy specimens.Sci Rep2020
32308085Salvage open radical prostatectomy for recurrent prostate cancer following MRI-guided transurethral ultrasound ablation (TULSA) of the prostate: feasibility and efficacy.Scand J Urol2020
30430700Characterization of clinical human prostate cancer lesions using 3.0-T sodium MRI registered to Gleason-graded whole-mount histopathology.J Magn Reson Imaging2019
30017404Active Surveillance Magnetic Resonance Imaging Study (ASIST): Results of a Randomized Multicenter Prospective Trial.Eur Urol2019
31433512A three-gene DNA methylation biomarker accurately classifies early stage prostate cancer.Prostate2019
28753797[<sup>18</sup>F]-DCFPyL Positron Emission Tomography/Magnetic Resonance Imaging for Localization of Dominant Intraprostatic Foci: First Experience.Eur Urol Focus2018
29989922Stochastic Modeling of Temporal Enhanced Ultrasound: Impact of Temporal Properties on Prostate Cancer Characterization.IEEE Trans Biomed Eng2018
28381150Incidental Prostate Adenocarcinoma in Cystoprostatectomy Specimens: Partial Versus Complete Prostate Sampling.Int J Surg Pathol2017
27217852Enumerating pelvic recurrence following radical cystectomy for bladder cancer: A Canadian multi-institutional study.Can Urol Assoc J2016
27375167Toward Prostate Cancer Contouring Guidelines on Magnetic Resonance Imaging: Dominant Lesion Gross and Clinical Target Volume Coverage Via Accurate Histology Fusion.Int J Radiat Oncol Biol Phys2016
25720016Ultrasound-Based Characterization of Prostate Cancer Using Joint Independent Component Analysis.IEEE Trans Biomed Eng2015
25935029Computer-Aided Prostate Cancer Detection Using Ultrasound RF Time Series: In Vivo Feasibility Study.IEEE Trans Med Imaging2015
25706976Cardiac, renal, and central nervous system dysfunction with eosinophilia: eosinophilic granulomatosis with polyangiitis.Lancet2015
24827423SKA1 over-expression promotes centriole over-duplication, centrosome amplification and prostate tumourigenesis.J Pathol2014
23739794Prostate histopathology: learning tissue component histograms for cancer detection and classification.IEEE Trans Med Imaging2013
24579151Ultrasound-based characterization of prostate cancer: an in vivo clinical feasibility study.Med Image Comput Comput Assist Interv2013
243922453D prostate histology image reconstruction: Quantifying the impact of tissue deformation and histology section location.J Pathol Inform2013
240071843D prostate histology reconstruction: an evaluation of image-based and fiducial-based algorithms.Med Phys2013
22474671Prostate: registration of digital histopathologic images to in vivo MR images acquired by using endorectal receive coil.Radiology2012
23048060TRIM59, a novel multiple cancer biomarker for immunohistochemical detection of tumorigenesis.BMJ Open2012
22851455Registration of prostate histology images to ex vivo MR images via strand-shaped fiducials.J Magn Reson Imaging2012
21242273Metastasis from renal cell carcinoma to the thyroid 12 years after nephrectomy.CMAJ2011
21593385Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models.Mol Cancer Ther2011
21502968The clinical significance of in-depth pathological assessment of extraprostatic extension and margin status in radical prostatectomies for prostate cancer.Prostate Cancer Prostatic Dis2011
21251474The pattern of prostate cancer local recurrence after radiation and salvage cryoablation.Can Urol Assoc J2011
20165574Ureteral frozen sections at the time of radical cystectomy: reliability and clinical implications.Can Urol Assoc J2010
20128686Immunohistochemical analysis of kallikrein-related peptidases in the normal kidney and renal tumors: potential clinical implications.Biol Chem2010
18822106Intravenous immunoglobulin as rescue therapy for BK virus nephropathy.Pediatr Transplant2009
19728975Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model.Mol Imaging2009
17579613Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer.Prostate Cancer Prostatic Dis2008
18708939Interobserver variability between expert urologic pathologists for extraprostatic extension and surgical margin status in radical prostatectomy specimens.Am J Surg Pathol2008
17363606Functional neoangiogenesis imaging of genetically engineered mouse prostate cancer using three-dimensional power Doppler ultrasound.Cancer Res2007
18542829A rare case of penile cancer in situ metastasizing to lymph nodes.Can Urol Assoc J2007
17698104Salvage cryoablation of the prostate: followup and analysis of predictive factors for outcome.J Urol2007
  • 1 - 50 of 81

Recommended Authors

Brian D Robinson
Sandra and Edward Meyer Cancer Center
Career Start Year 2008
Number of shared co-authors 2
Brian W Simons
Center for Comparative Medicine, Baylor College of Medicine
Career Start Year 2008
Number of shared co-authors 1
Huihui Ye
College of Optical Science and Engineering, Zhejiang University
Career Start Year 2004
Number of shared co-authors 6
Anne Y Warren
Cambridge University Hospitals National Health Service Foundation Trust
Career Start Year 2003
Number of shared co-authors 4
Mathieu Latour
Centre Hospitalier de l'Universite de Montreal
Career Start Year 2001
Number of shared co-authors 11
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 2
H??l??ne Hovington
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1999
Number of shared co-authors 8
Geert J L H van Leenders
Erasmus MC Cancer Institute, University Medical Center
Career Start Year 1998
Number of shared co-authors 10
David Clouston
Career Start Year 1995
Number of shared co-authors 6
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Career Start Year 1994
Number of shared co-authors 2
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 0
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Career Start Year 1993
Number of shared co-authors 3
Marshall Scott Lucia
University of Colorado School of Medicine
Career Start Year 1991
Number of shared co-authors 8
Mark A Rubin
University of Bern
Career Start Year 1990
Number of shared co-authors 9
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
Javed Siddiqui
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 1988
Number of shared co-authors 5
Anders Bjartell
Skane University Hospital, Lund University
Career Start Year 1987
Number of shared co-authors 4
Alan W Partin
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1987
Number of shared co-authors 1
Peter A Humphrey
Yale University School of Medicine
Career Start Year 1986
Number of shared co-authors 8
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 4
Eric A Klein
Cleveland Clinic
Career Start Year 1984
Number of shared co-authors 13
Victor E Reuter
Memorial Sloan Kettering Cancer Center
Career Start Year 1983
Number of shared co-authors 10
Kenneth J Pienta
The Brady Urological Institute, Johns Hopkins University School of Medicine
Career Start Year 1981
Number of shared co-authors 3
Lawrence D True
University of Washington School of Medicine
Career Start Year 1980
Number of shared co-authors 10
Bernard T??tu
Centre de Recherche du CHU de Quebec-Universite Laval (axe Oncologie)
Career Start Year 1979
Number of shared co-authors 12
Christopher S Foster
The Institute of Cancer Research
Career Start Year 1978
Number of shared co-authors 4
Cathy Corbishley
The Institute of Cancer Research
Career Start Year 1977
Number of shared co-authors 2
Daniel M Berney
Barts Cancer Institute, Queen Mary University of London
Career Start Year 1975
Number of shared co-authors 7
Robert L Vessella
University of Washington
Career Start Year 1974
Number of shared co-authors 2
William E Grizzle
University of Alabama at Birmingham
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Joseph L Chin
University of Western Ontario
Co-authored papers 44
Glenn Bauman
Western University and London Regional Cancer Program
Co-authored papers 26
Neil E Fleshner
University of Toronto
Co-authored papers 5
Irina Rachinsky
University of Western Ontario
Co-authored papers 5
David Robert Siemens
Queen's University
Co-authored papers 5
Theodorus H van der Kwast
University Health Network, University of Toronto
Co-authored papers 4
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 3
James C Lacefield
Western University
Co-authored papers 3
David M Berman
Queen's University
Co-authored papers 3
Fadi Brimo
McGill University Health Centre, McGill University
Co-authored papers 3
Hagit Shatkay
University of Delaware
Co-authored papers 3
Masoom A Haider
University Health Network
Co-authored papers 3
Danny Vesprini
University of Toronto, Canada Odette Cancer Centre
Co-authored papers 2
Palak G Patel
Queen's University
Co-authored papers 2
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Co-authored papers 2
Andrew J Evans
Princess Margaret Cancer Center, University Health Network.
Co-authored papers 2
Nathan E How
Queen's University Cancer Research Institute
Co-authored papers 2
Antonio Finelli
Princess Margaret Cancer Centre, University Health Network and University of Toronto
Co-authored papers 2
Edward C Jones
University of British Columbia
Co-authored papers 2
James Koropatnick
Western University, Lawson Health Research Institute
Co-authored papers 2
Karl-Philippe Gu??rard
McGill University and the Research Institute of the McGill University Health Centre
Co-authored papers 2
Jane Bayani
Ontario Institute for Cancer Research
Co-authored papers 2
Eleonora Scarlata
Research Institute of the McGill University Health Center (RI-MUHC)
Co-authored papers 2
Tamara Jamaspishvili
Queen's University
Co-authored papers 2
Paul C Boutros
University of California los angeles
Co-authored papers 2
John M S Bartlett
University of Edinburgh
Co-authored papers 2
John R Srigley
University of Toronto
Co-authored papers 2
Dan Dion
Ontario Institute for Cancer Research (OICR)
Co-authored papers 1
Anna Y Lee
Ontario Institute for Cancer Research
Co-authored papers 1
Laura Lee
Ontario Institute for Cancer Research (OICR)
Co-authored papers 1
Release 1.2